RBX1 anticorps (C-Term)

N° du produit ABIN1944784

Détail du produit anti-RBX1 anticorps

Antigène: RBX1 (Ring-Box 1, E3 Ubiquitin Protein Ligase (RBX1))

Épitope: AA 74-108, C-Term

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp RBX1 est non-conjugé

Application: Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Homologie: E

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This RBX1 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 74-108 amino acids from the C-terminal region of human RBX1.

Clone: RB48352

Isotype: Ig Fraction

Information d'application

Indications d'application: IF: 1:25. WB: 1:1000. WB: 1:1000. WB: 1:1000. WB: 1:1000. IHC-P: 1:25. IHC-P: 1:25

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Références pour anticorps anti-RBX1 (ABIN1944784)

Ohta, Michel, Schottelius, Xiong: "ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity." dans: Molecular cell, Vol. 3, Issue 4, pp. 535-41, (1999) (PubMed).

Kamura, Koepp, Conrad, Skowyra, Moreland, Iliopoulos, Lane, Kaelin, Elledge, Conaway, Harper, Conaway: "Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase." dans: Science (New York, N.Y.), Vol. 284, Issue 5414, pp. 657-61, (1999) (PubMed).

Détails sur RBX1

Antigène: RBX1 (Ring-Box 1, E3 Ubiquitin Protein Ligase (RBX1))

Autre désignation: RBX1 (RBX1 Produits)

Synonymes: anticorps BA554C12.1, anticorps RNF75, anticorps ROC1, anticorps 1500002P15Rik, anticorps AA517855, anticorps im:7137515, anticorps zgc:136444, anticorps RBX1, anticorps ATRBX1, anticorps F7C8.160, anticorps F7C8_160, anticorps HRT1, anticorps REGULATOR OF CULLINS-1, anticorps RING-BOX 1, anticorps RING-box 1, anticorps hop21, anticorps BEST:CK01110, anticorps CG16982, anticorps CK01110, anticorps Dmel\CG16982, anticorps EG:115C2.11, anticorps Rbx1, anticorps Rbx1/Roc, anticorps Roc, anticorps Roc1alpha, anticorps anon-EST:Posey65, anticorps dRbx1, anticorps dRoc1, anticorps dRoc1a, anticorps ring-box 1, anticorps ring-box 1, E3 ubiquitin protein ligase, anticorps RING-box 1, anticorps RING-box protein 1, anticorps RING-box protein 1a, anticorps Regulator of cullins 1a, anticorps RBX1, anticorps Rbx1, anticorps rbx1, anticorps MGG_08844, anticorps LOC9308017, anticorps rbx-1, anticorps Roc1a

Sujet: E3 ubiquitin ligase component of multiple cullin-RING- based E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins, including proteins involved in cell cycle progression, signal transduction, transcription and transcription-coupled nucleotide excision repair. The functional specificity of the E3 ubiquitin-protein ligase complexes depends on the variable substrate recognition components. As a component of the CSA complex promotes the ubiquitination of ERCC6 resulting in proteasomal degradation. Through the RING-type zinc finger, seems to recruit the E2 ubiquitination enzyme, like CDC34, to the complex and brings it into close proximity to the substrate. Probably also stimulates CDC34 autoubiquitination. May be required for histone H3 and histone H4 ubiquitination in response to ultraviolet and for subsequent DNA repair. Promotes the neddylation of CUL1, CUL2, CUL4 and CUL4 via its interaction with UBE2M. Involved in the ubiquitination of KEAP1, ENC1 and KLHL41. In concert with ATF2 and CUL3, promotes degradation of KAT5 thereby attenuating its ability to acetylate and activate ATM.

Poids moléculaire: 12274

ID gène: 9978

UniProt: P62877

Pathways: Cycle Cellulaire, M Phase, SARS-CoV-2 Protein Interactome